Genetically engineered mouse colitis models are increasing the flexibility and predictive validity of preclinical colitis models in inflammatory bowel disease (IBD) research. These powerful tools are increasingly supplementing or replacing traditional chemically induced models (e.g. DSS- or TNBS-induced colitis), and offer important translational and mechanistic insights in IBD drug development.
View this webinar to learn about the role of the microbiome in colitis models. By watching you can learn:
Watch the On-Demand Webinar at Taconic Webinars